Table 4. The prevalence of H. pylori antibiotic resistance in Southeast Asian countries.
Countries, year | Number of patients | TET | AMX | CLR | LVX | MTZ | MDR | References |
---|---|---|---|---|---|---|---|---|
Vietnam, 2019 | 2,318 | 17.9 | 15.0 | 34.1 | 27.9 | 69.4 | 48.8 | Khien et al. [25] |
Philippines, 2019 | 42 | 0 | 0 | 28.6 | 61.9 | 40.5 | N/A | Yumang et al. [26] |
Cambodia, 2019 | 55 | 0 | 9.1 | 25.5 | 67.3 | 96.4 | 76.4 | Tuan et al. [27] |
Thailand, 2022 | 192 | 0 | 2.1 | 24.0 | 33.9 | 43.2 | 27.6 | This study |
Singapore, 2016 | 708 | 7.6 | 4.1 | 17.1 | 14.7 | 48.2 | 13.5 | Ang et al. [28] |
Laos, 2016 | 31 | N/A | N/A | 12.6 | 13.4 | N/A | N/A | Vannarath et al. [29] |
Malaysia, 2019 | 59 | 0 | 0 | 12.2 | 17.1 | 56.1 | 40.9 | Hanafiah et al. [30] |
Indonesia, 2016 | 77 | 2.6 | 5.2 | 9.1 | 31.2 | 46.7 | 24.7 | Miftahussurur et al. [31] |
Myanmar, 2022 | 65 | 0 | 4.6 | 7.7 | 33.8 | 80.0 | 33.8 | Subsomwong et al. [32] |
TET = Tetracycline, AMX = Amoxicillin, CLR = Clarithromycin, LVX = Levofloxacin, MTZ = Metronidazole, MDR = Multidrug-resistant strains, N/A = Not available